Effect of estrogen on exercise electrocardiograms in healthy postmenopausal women
Digoxin has been shown to produce a false-positive exercise electrocardiographic response (ST-segment depression) in about 25% of study subjects.1 Estrogen—which shares certain chemical similarities with digoxin including a steroid nucleus—has been implicated as a cause of a false-positive exercise...
Gespeichert in:
Veröffentlicht in: | The American journal of cardiology 2000-08, Vol.86 (4), p.477-479 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 479 |
---|---|
container_issue | 4 |
container_start_page | 477 |
container_title | The American journal of cardiology |
container_volume | 86 |
creator | Rovang, Karen S Arouni, Amy J Mohiuddin, Syed M Tejani, Aaron Hilleman, Daniel E |
description | Digoxin has been shown to produce a false-positive exercise electrocardiographic response (ST-segment depression) in about 25% of study subjects.1 Estrogen—which shares certain chemical similarities with digoxin including a steroid nucleus—has been implicated as a cause of a false-positive exercise electrocardiographic response.2 This finding was based on a retrospective study that was not adequately designed to address the causal role of estrogen in producing false-positive stress tests. Age, history of smoking, hypercholesterolemia, diabetes, hypertension, obesity, drug therapy, exercise duration, peak exercise heart rate and blood pressure, concomitant use of progesterone, and prior use of hormone replacement therapy were not predictive of a positive electrocardiographic response. [...]we have demonstrated that approximately 20% of postmenopausal women with a normal baseline stress echocardiogram will have a false-positive exercise electrocardiographic response to oral exogenous estrogen therapy. |
doi_str_mv | 10.1016/S0002-9149(00)00974-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71753494</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914900009747</els_id><sourcerecordid>2046545164</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-f05176db59fac526e0a45dbfa062e809590de8b14bdcdc55e8b0a0ef4c4f10243</originalsourceid><addsrcrecordid>eNqFkVFrFTEQhYNY7LX6E5SgIvVhdWY32b15Eim1FQoi6nPIJpM2ZXdzm-yq_ffm9l5UBPEpGeabw-Ecxp4gvEbA9s1nAKgrhUIdA7wCUJ2ountshetOVaiwuc9Wv5BD9jDn6zIiyvYBO0RQogVZr9inU-_Jzjx6TnlO8ZImHidOPyjZkInTULYpWpNciJfJjJmHiV-RGearW76JeR5pihuzZDPw77EMj9iBN0Omx_v3iH19f_rl5Ly6-Hj24eTdRWWFkHPlQWLXul4qb6ysWwIjpOu9gbamNSipwNG6R9E766yU5Q8GyAsrPEItmiP2cqe7SfFmKeb1GLKlYTATxSXrDjvZCLUFn_0FXsclTcWbrhtoZKdQFuj5PyEQrRQS262U3FE2xZwTeb1JYTTpViPobS36rha9zVwD6LtadFfunu7Vl34k98fVrocCvNgDJlsz-GSmEv9vTnRYyivY2x1GJdhvgZLONtBkyYVUetIuhv84-Qm_dajM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2046545164</pqid></control><display><type>article</type><title>Effect of estrogen on exercise electrocardiograms in healthy postmenopausal women</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Rovang, Karen S ; Arouni, Amy J ; Mohiuddin, Syed M ; Tejani, Aaron ; Hilleman, Daniel E</creator><creatorcontrib>Rovang, Karen S ; Arouni, Amy J ; Mohiuddin, Syed M ; Tejani, Aaron ; Hilleman, Daniel E</creatorcontrib><description>Digoxin has been shown to produce a false-positive exercise electrocardiographic response (ST-segment depression) in about 25% of study subjects.1 Estrogen—which shares certain chemical similarities with digoxin including a steroid nucleus—has been implicated as a cause of a false-positive exercise electrocardiographic response.2 This finding was based on a retrospective study that was not adequately designed to address the causal role of estrogen in producing false-positive stress tests. Age, history of smoking, hypercholesterolemia, diabetes, hypertension, obesity, drug therapy, exercise duration, peak exercise heart rate and blood pressure, concomitant use of progesterone, and prior use of hormone replacement therapy were not predictive of a positive electrocardiographic response. [...]we have demonstrated that approximately 20% of postmenopausal women with a normal baseline stress echocardiogram will have a false-positive exercise electrocardiographic response to oral exogenous estrogen therapy.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/S0002-9149(00)00974-7</identifier><identifier>PMID: 10946052</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Administration, Oral ; Age ; Aged ; Biological and medical sciences ; Cardiovascular disease ; Chemical fingerprinting ; Chemotherapy ; Coronary vessels ; Diabetes ; Drug Administration Schedule ; Echocardiography ; Electrocardiography ; Electrocardiography - drug effects ; Estrogens ; Estrogens, Conjugated (USP) - administration & dosage ; Estrogens, Conjugated (USP) - pharmacology ; Exercise Test ; False Positive Reactions ; Family medical history ; Female ; Health risk assessment ; Heart rate ; Hormone replacement therapy ; Hormones. Endocrine system ; Humans ; Hypertension ; Medical sciences ; Medroxyprogesterone - administration & dosage ; Medroxyprogesterone - pharmacology ; Menopause ; Middle Aged ; Organic chemistry ; Pharmacology. Drug treatments ; Post-menopause ; Postmenopause - physiology ; Progesterone Congeners - administration & dosage ; Progesterone Congeners - pharmacology ; Steroids ; Ultrasonic imaging ; Women</subject><ispartof>The American journal of cardiology, 2000-08, Vol.86 (4), p.477-479</ispartof><rights>2000 Excerpta Medica Inc.</rights><rights>2000 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Aug 15, 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-f05176db59fac526e0a45dbfa062e809590de8b14bdcdc55e8b0a0ef4c4f10243</citedby><cites>FETCH-LOGICAL-c445t-f05176db59fac526e0a45dbfa062e809590de8b14bdcdc55e8b0a0ef4c4f10243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0002-9149(00)00974-7$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1471001$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10946052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rovang, Karen S</creatorcontrib><creatorcontrib>Arouni, Amy J</creatorcontrib><creatorcontrib>Mohiuddin, Syed M</creatorcontrib><creatorcontrib>Tejani, Aaron</creatorcontrib><creatorcontrib>Hilleman, Daniel E</creatorcontrib><title>Effect of estrogen on exercise electrocardiograms in healthy postmenopausal women</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Digoxin has been shown to produce a false-positive exercise electrocardiographic response (ST-segment depression) in about 25% of study subjects.1 Estrogen—which shares certain chemical similarities with digoxin including a steroid nucleus—has been implicated as a cause of a false-positive exercise electrocardiographic response.2 This finding was based on a retrospective study that was not adequately designed to address the causal role of estrogen in producing false-positive stress tests. Age, history of smoking, hypercholesterolemia, diabetes, hypertension, obesity, drug therapy, exercise duration, peak exercise heart rate and blood pressure, concomitant use of progesterone, and prior use of hormone replacement therapy were not predictive of a positive electrocardiographic response. [...]we have demonstrated that approximately 20% of postmenopausal women with a normal baseline stress echocardiogram will have a false-positive exercise electrocardiographic response to oral exogenous estrogen therapy.</description><subject>Administration, Oral</subject><subject>Age</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular disease</subject><subject>Chemical fingerprinting</subject><subject>Chemotherapy</subject><subject>Coronary vessels</subject><subject>Diabetes</subject><subject>Drug Administration Schedule</subject><subject>Echocardiography</subject><subject>Electrocardiography</subject><subject>Electrocardiography - drug effects</subject><subject>Estrogens</subject><subject>Estrogens, Conjugated (USP) - administration & dosage</subject><subject>Estrogens, Conjugated (USP) - pharmacology</subject><subject>Exercise Test</subject><subject>False Positive Reactions</subject><subject>Family medical history</subject><subject>Female</subject><subject>Health risk assessment</subject><subject>Heart rate</subject><subject>Hormone replacement therapy</subject><subject>Hormones. Endocrine system</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Medical sciences</subject><subject>Medroxyprogesterone - administration & dosage</subject><subject>Medroxyprogesterone - pharmacology</subject><subject>Menopause</subject><subject>Middle Aged</subject><subject>Organic chemistry</subject><subject>Pharmacology. Drug treatments</subject><subject>Post-menopause</subject><subject>Postmenopause - physiology</subject><subject>Progesterone Congeners - administration & dosage</subject><subject>Progesterone Congeners - pharmacology</subject><subject>Steroids</subject><subject>Ultrasonic imaging</subject><subject>Women</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkVFrFTEQhYNY7LX6E5SgIvVhdWY32b15Eim1FQoi6nPIJpM2ZXdzm-yq_ffm9l5UBPEpGeabw-Ecxp4gvEbA9s1nAKgrhUIdA7wCUJ2ountshetOVaiwuc9Wv5BD9jDn6zIiyvYBO0RQogVZr9inU-_Jzjx6TnlO8ZImHidOPyjZkInTULYpWpNciJfJjJmHiV-RGearW76JeR5pihuzZDPw77EMj9iBN0Omx_v3iH19f_rl5Ly6-Hj24eTdRWWFkHPlQWLXul4qb6ysWwIjpOu9gbamNSipwNG6R9E766yU5Q8GyAsrPEItmiP2cqe7SfFmKeb1GLKlYTATxSXrDjvZCLUFn_0FXsclTcWbrhtoZKdQFuj5PyEQrRQS262U3FE2xZwTeb1JYTTpViPobS36rha9zVwD6LtadFfunu7Vl34k98fVrocCvNgDJlsz-GSmEv9vTnRYyivY2x1GJdhvgZLONtBkyYVUetIuhv84-Qm_dajM</recordid><startdate>20000815</startdate><enddate>20000815</enddate><creator>Rovang, Karen S</creator><creator>Arouni, Amy J</creator><creator>Mohiuddin, Syed M</creator><creator>Tejani, Aaron</creator><creator>Hilleman, Daniel E</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20000815</creationdate><title>Effect of estrogen on exercise electrocardiograms in healthy postmenopausal women</title><author>Rovang, Karen S ; Arouni, Amy J ; Mohiuddin, Syed M ; Tejani, Aaron ; Hilleman, Daniel E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-f05176db59fac526e0a45dbfa062e809590de8b14bdcdc55e8b0a0ef4c4f10243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Administration, Oral</topic><topic>Age</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular disease</topic><topic>Chemical fingerprinting</topic><topic>Chemotherapy</topic><topic>Coronary vessels</topic><topic>Diabetes</topic><topic>Drug Administration Schedule</topic><topic>Echocardiography</topic><topic>Electrocardiography</topic><topic>Electrocardiography - drug effects</topic><topic>Estrogens</topic><topic>Estrogens, Conjugated (USP) - administration & dosage</topic><topic>Estrogens, Conjugated (USP) - pharmacology</topic><topic>Exercise Test</topic><topic>False Positive Reactions</topic><topic>Family medical history</topic><topic>Female</topic><topic>Health risk assessment</topic><topic>Heart rate</topic><topic>Hormone replacement therapy</topic><topic>Hormones. Endocrine system</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Medical sciences</topic><topic>Medroxyprogesterone - administration & dosage</topic><topic>Medroxyprogesterone - pharmacology</topic><topic>Menopause</topic><topic>Middle Aged</topic><topic>Organic chemistry</topic><topic>Pharmacology. Drug treatments</topic><topic>Post-menopause</topic><topic>Postmenopause - physiology</topic><topic>Progesterone Congeners - administration & dosage</topic><topic>Progesterone Congeners - pharmacology</topic><topic>Steroids</topic><topic>Ultrasonic imaging</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rovang, Karen S</creatorcontrib><creatorcontrib>Arouni, Amy J</creatorcontrib><creatorcontrib>Mohiuddin, Syed M</creatorcontrib><creatorcontrib>Tejani, Aaron</creatorcontrib><creatorcontrib>Hilleman, Daniel E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Physical Education Index</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rovang, Karen S</au><au>Arouni, Amy J</au><au>Mohiuddin, Syed M</au><au>Tejani, Aaron</au><au>Hilleman, Daniel E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of estrogen on exercise electrocardiograms in healthy postmenopausal women</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2000-08-15</date><risdate>2000</risdate><volume>86</volume><issue>4</issue><spage>477</spage><epage>479</epage><pages>477-479</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Digoxin has been shown to produce a false-positive exercise electrocardiographic response (ST-segment depression) in about 25% of study subjects.1 Estrogen—which shares certain chemical similarities with digoxin including a steroid nucleus—has been implicated as a cause of a false-positive exercise electrocardiographic response.2 This finding was based on a retrospective study that was not adequately designed to address the causal role of estrogen in producing false-positive stress tests. Age, history of smoking, hypercholesterolemia, diabetes, hypertension, obesity, drug therapy, exercise duration, peak exercise heart rate and blood pressure, concomitant use of progesterone, and prior use of hormone replacement therapy were not predictive of a positive electrocardiographic response. [...]we have demonstrated that approximately 20% of postmenopausal women with a normal baseline stress echocardiogram will have a false-positive exercise electrocardiographic response to oral exogenous estrogen therapy.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>10946052</pmid><doi>10.1016/S0002-9149(00)00974-7</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9149 |
ispartof | The American journal of cardiology, 2000-08, Vol.86 (4), p.477-479 |
issn | 0002-9149 1879-1913 |
language | eng |
recordid | cdi_proquest_miscellaneous_71753494 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Administration, Oral Age Aged Biological and medical sciences Cardiovascular disease Chemical fingerprinting Chemotherapy Coronary vessels Diabetes Drug Administration Schedule Echocardiography Electrocardiography Electrocardiography - drug effects Estrogens Estrogens, Conjugated (USP) - administration & dosage Estrogens, Conjugated (USP) - pharmacology Exercise Test False Positive Reactions Family medical history Female Health risk assessment Heart rate Hormone replacement therapy Hormones. Endocrine system Humans Hypertension Medical sciences Medroxyprogesterone - administration & dosage Medroxyprogesterone - pharmacology Menopause Middle Aged Organic chemistry Pharmacology. Drug treatments Post-menopause Postmenopause - physiology Progesterone Congeners - administration & dosage Progesterone Congeners - pharmacology Steroids Ultrasonic imaging Women |
title | Effect of estrogen on exercise electrocardiograms in healthy postmenopausal women |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T10%3A46%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20estrogen%20on%20exercise%20electrocardiograms%20in%20healthy%20postmenopausal%20women&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Rovang,%20Karen%20S&rft.date=2000-08-15&rft.volume=86&rft.issue=4&rft.spage=477&rft.epage=479&rft.pages=477-479&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/S0002-9149(00)00974-7&rft_dat=%3Cproquest_cross%3E2046545164%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2046545164&rft_id=info:pmid/10946052&rft_els_id=S0002914900009747&rfr_iscdi=true |